Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
Cancer Prev Res (Phila). 2010 Jun;3(6):787-96. doi: 10.1158/1940-6207.CAPR-09-0243. Epub 2010 May 25.
Cancer Prev Res (Phila). 2010.
PMID: 20501859
Free PMC article.
Therefore, celecoxib, a selective inhibitor of COX-2, was hailed as a promising chemopreventive agent for HNSCC. Dose-dependent cardiac toxicity limits long-term use of celecoxib, but it seems likely that this may be diminished by lowering its dose. ...
Therefore, celecoxib, a selective inhibitor of COX-2, was hailed as a promising chemopreventive agent for HNSCC. Dose-dependent cardiac toxi …
The role of translational research in addressing health disparities: a conceptual framework.
Fleming ES, Perkins J, Easa D, Conde JG, Baker RS, Southerland WM, Dottin R, Benabe JE, Ofili EO, Bond VC, McClure SA, Sayre MH, Beanan MJ, Norris KC.
Fleming ES, et al. Among authors: southerland wm.
Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-155-60.
Ethn Dis. 2008.
PMID: 18646340
Free PMC article.
Translational research has tremendous potential as a tool to reduce health disparities in the United States, but a lack of common understanding about the scope of this dynamic, multidisciplinary approach to research has limited its use. The term "translational research" is …
Translational research has tremendous potential as a tool to reduce health disparities in the United States, but a lack of common understand …
Item in Clipboard
The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexate.
Das JR, Fryar EB, Green S, Southerland WM, Bowen D.
Das JR, et al. Among authors: southerland wm.
Anticancer Res. 2006 Nov-Dec;26(6B):4279-86.
Anticancer Res. 2006.
PMID: 17201145
Free article.
The success of the first clinically relevant selective estrogen receptor modulator (SERM), tamoxifen, provided the foundation for further testing of this drug to reduce breast cancer incidence in high-risk women. However, the negative effects associated with the long-term …
The success of the first clinically relevant selective estrogen receptor modulator (SERM), tamoxifen, provided the foundation for further te …
Item in Clipboard
Cite
Cite